Quick Answer
cbdMD, Inc. reported Diluted EPS of $13.32 per share (loss) for fiscal year 2023.
cbdMD, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$13.32 | +76.1% |
| 2022 | -$55.80 | -11772.3% |
| 2021 | -$0.47 | -267.9% |
| 2020 | $0.28 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | -$0.15 | +87.1% | +88.9% |
| March 31, 2024 | -$1.35 | +22.4% | -16.4% |
| June 30, 2023 | -$1.16 | +95.3% | +33.3% |
| March 31, 2023 | -$1.74 | +59.7% | -2075.0% |
| December 31, 2022 | -$0.08 | +77.1% | +99.7% |
| June 30, 2022 | -$24.81 | -124150.0% | -474.3% |
| March 31, 2022 | -$4.32 | -1700.0% | -1134.3% |
| December 31, 2021 | -$0.35 | -94.4% | -1850.0% |
- cbdMD, Inc. showed an increase of +76.1% in Diluted EPS compared to the prior fiscal year.
- The most recent figure is from cbdMD, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on December 22, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: